Clinical Trials Directory

Trials / Completed

CompletedNCT04026581

Real World Testing of a Brain-Computer Interface

Real World Testing of a Brain-Computer Interface to Operate a Commercial Augmentative and Alternative Communication System

Status
Completed
Phase
Study type
Observational
Enrollment
19 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The goal of this project is to test a new AAC-BCI device comparing gel and dry electrode headgear used for communication while providing clinical care. Innovative resources will be employed to support the standard of care without considering limitations based on service billing codes. Clinical services will include AAC assessment, AAC-BCI device and treatment to individuals with minimal movement due to amyotrophic lateral sclerosis (ALS), brain stem strokes, severe cerebral palsy, traumatic brain injury (TBI) and their family support person. This is a descriptive study designed to measure and monitor the communication performance of individuals using the AAC-BCI, any other AAC strategies, their user satisfaction and perceptions of communication effectiveness, and the satisfaction of the family support persons.

Detailed description

This clinical trial follows a descriptive study design collecting data to measure and monitor variables related to the standard of care in providing speech language pathology augmentative and alternative communication clinical (AAC) assessment and treatment. The study tracks participants through the AAC, speech generating device trial and AAC-BCI trial processes. In addition this study measures and monitors the communication performance of individuals using the AAC-BCI and any other AAC strategies for treatment in the home. Data on communication performance, user satisfaction, and perceptions of communication effectiveness are gathered over monthly visits along with the satisfaction and perceptions of communication effectiveness by the family support persons.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSpeech generating device (SGD) evaluation including BCI accessAt the initial evaluation the participants will review the full range of AAC options and speech generating devices (SGDs) and complete a speech and language evaluation. The second evaluation date will involve a trial of SGDs matched to the participant's assessment results. The third visit is the trial of an AAC system with BCI access. Should the dry electrode headgear for BCI access prove ineffective, then the gel electrode cap will be offered to the participant for trial. At the end of the third visit, the evaluation results will be discussed with participant and family, and they will be asked to select the preferred SGD.
BEHAVIORALTraining and treatmentParticipants receive training on the selected SGD followed by monthly treatment sessions from the SLP who monitors performance. In some cases the participants' SGD will be an AAC system with BCI access. In this case training will also include an identified system support person. Use of the SGD is monitored on a monthly basis through home visits and/or tele-practice sessions, when requested. Technical support for the SGD is provided on an as needed basis or when requested by the participant or support person.

Timeline

Start date
2019-06-05
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2019-07-19
Last updated
2023-12-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04026581. Inclusion in this directory is not an endorsement.